Document Detail


Change in treatment strategy for intracranial germinoma: long-term follow-up experience at a single institute.
MedLine Citation:
PMID:  21989828     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Previous intracranial germinoma (IG) studies have investigated the effect of different radiotherapy (RT) volumes and the necessity for adjunctive chemotherapy, but there is currently no consensus on the best treatment for this tumor. METHODS: From January 1989 to December 2009, 80 IG patients (≤20 years old) were treated with various RT regimens. Of them, 14 patients had craniospinal irradiation (CSI) + primary boost (PB); 8 patients had whole-brain irradiation (WBI) + PB; 31 patients had whole ventricular irradiation (WVI) + PB; and 27 patients had focal RT only. Twenty-nine patients (36.2%) also received systemic chemotherapy (CHT). Survival was estimated by the Kaplan-Meier method and variables affecting survival were analyzed by the Cox proportional hazard model. RESULTS: Eleven patients (13.8%) developed local recurrence or dissemination after treatment, and 10 of these patients were in the focal RT group. The 5-year relapse-free survival (RFS) for the CSI, WBI, WVI, and focal RT patients were 100%, 85.7%, 100%, and 84.6%, respectively (P = .001). The 5-year overall survival (OS) for CSI, WBI, WVI, and focal RT patients was 100%, 83.3%, 100%, and 87.9%, respectively (P = .125). Focal irradiation (P = .02) and initial use of CHT (P = .021) were negatively associated with RFS. CONCLUSIONS: Focal RT plus CHT were associated with inferior control of IG and a higher incidence of CHT-related toxicities. Adjustment of the radiation volume to the whole ventricular system without CHT is sufficient for treatment of nondisseminated IGs, even with lower primary RT doses (<36 Gy). Cancer 2011. © 2011 American Cancer Society.
Authors:
Yi-Wei Chen; Pin-I Huang; Donald Ming-Tak Ho; Yu-Wen Hu; Kai-Ping Chang; Shih-Hwa Chiou; Wan-Yuo Guo; Feng-Chi Chang; Muh-Lii Liang; Yi-Yen Lee; Hsin-Hung Chen; Ting-Rong Hsu; Shih-Chieh Lin; Tai-Tong Wong; Sang-Hue Yen
Related Documents :
9681128 - The use of lenograstim (granocyte) in chemotherapy for ovarian cancer.
2016618 - Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and pre...
6507378 - A phase ii study of dibromodulcitol (dbd) in stage iv melanoma.
7839898 - Rapid control of chronic granulocytic leukaemia.
10912978 - Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding.
9364658 - Management strategies for colorectal liver metastases--part i.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-11
Journal Detail:
Title:  Cancer     Volume:  -     ISSN:  1097-0142     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 American Cancer Society.
Affiliation:
Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan; Division of Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; Cancer Center, Taipei Veterans General Hospital, Taipei, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Homogeneous ice nucleation from supercooled water.
Next Document:  Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplanta...